pSTAT5 is detected in human
breast early lesions, especially in women who have had a pregnancy; therefore, prophylactic therapy targeting Jak2 - STAT5 signaling may lower breast cancer risk in high risk women.
Not exact matches
Widespread
breast screening has led to
early detection and a new dilemma: whether to aggressively treat noncancerous
lesions that may never become invasive or whether to «watch and wait.»
«We showed that expansion can help us better computationally classify these
early breast lesions,» said Bucur.
Dr. Harold Varmus: Well for example it's very likely that
early breast lesions that are called introductoral carcinomas called in situ
lesions frequently will probably never progress and we need ways to be able to predict which will and which won't progress.